Free shipping on all orders over $ 500

MYC-IN-3

Cat. No. M59313

All AbMole products are for research use only, cannot be used for human consumption.

MYC-IN-3 Structure
Size Price Availability Quantity
5mg USD 180 In stock
10mg USD 275 In stock
25mg USD 460 In stock
50mg USD 690 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

MYC-IN-3 is a potent MYC inhibitor. MYC-IN-3 shows antiproliferative and anticancer activity. MYC-IN-3 inhibits the binding of MYC/MYC-associated protein X (MAX) heterodimer to DNA consensus sequence, induce MYC thermal instability, and disturb MYC/MAX interaction. MYC-IN-3 exhibited superior antiproliferative activities to those of MYCi975 against multiple malignant cell lines. It induced dose-dependent MYC degradation in cells with degradation observed at the concentration as low as 1.0 μM.

MYC-IN-3 demonstrated enhanced therapeutic efficacy over MYCi975 in a mouse allograft model of prostate cancer. MYC-IN-3 can be used in the research of prostate cancer.

Chemical Information
Molecular Weight 543.89
Formula C25H20ClF6N3O2
CAS Number 3042878-82-7
Solubility (25°C) DMSO 100 mg/mL
Storage Powder -20°C
Related c-Myc Products
10058-F4

10058-F4 is a c-Myc inhibitor that specificallly inhibits the c-Myc-Max interaction and prevents transactivation of c-Myc target gene expression.

10074-G5

10074-G5 is a c-Myc/Max interaction inhibitor, which binds to a different specific binding site (region) of C-Myc than 10054-F4.

ML327

ML327 is a blocker of MYC, which mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition.

MYCi975

MYCi975 (Nuc-0200975) is an orally active MYC inhibitor that disrupts MYC/MAX interactions, promotes MYC T58 phosphorylation and MYC degradation, and impairs myC-driven gene expression. MYCi975 (NUC-0200975) has strong anti-tumor effect and good tolerance, increasing tumor immune cell infiltration and enhancing tumor sensitivity against PD1 immune studies.

APTO-253

APTO-253 (LOR-253) is a small molecule that inhibits c-Myc expression, stabilizes G-quadruplex DNA, and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells.

  Catalog
Abmole Inhibitor Catalog




Keywords: MYC-IN-3 supplier, c-Myc, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.